Pharmaceutical companies spend a lot of money to develop new blockbuster drugs — for research and to shepherd the meds through clinical trials. And of course, pharma tries to maximize profits once those drugs are on the market, with programs to encourage doctors to prescribe them and patients to stay on them.
There are pretty strict laws barring the companies from outright paying off doctors by giving them lavish trips or valuable swag to get them to write more prescriptions.
But some major drug companies are offering other, more indirect benefits to doctors and patients to pump up prescriptions. Last week, the California insurance commissioner sued AbbVie, the maker of Humira, a top-selling arthritis drug, over alleged kickbacks. The Wall Street Journal reports that several other companies are under investigation or the subject of lawsuits for similar tactics.
Right now, federal law bans drug companies from doling out cash or gifts to induce doctors to prescribe specific drugs.
“They used to send doctors on cruises and they’d send them to Hawaii golfing, and so we’ve kind of moved away from that,” said Lisa Gill, deputy content editor at Consumer Reports.
But Gill said drug companies have gotten creative. They help cover prescription drug copays and send nurses on home visits, which help patients but also encourage drug sales.
“It would be great if nurses could be sent to everybody’s house,” she said. “A drug assistance program can be the lifeline — the difference between getting a medication and not.”
Drug companies also have new incentives for doctors, and that could be more problematic, said Vivian Ho, director of the Center for Health and Bioscience at Rice University. For instance, providing “reimbursement support services” to help medical offices navigate the health insurance system.
“Sending staff to fill out the paperwork for reimbursements? That’s an inducement to increase the amount of usage of their drugs,” Ho said. Ho said that could be illegal if it involves a government health program.
It may seem like doctors are saving patients money when they work with pharmaceutical companies, said Genevieve Kanter, a medical ethicist at the University of Pennsylvania, but doctors need to disclose any “incentives” drug companies are offering.
“There may be other medications that may be better for them than the medications they’re getting the subsidies for,” she said.
Click the audio player above to hear the full story.
If you’re a member of your local public radio station, we thank you — because your support helps those stations keep programs like Marketplace on the air. But for Marketplace to continue to grow, we need additional investment from those who care most about what we do: superfans like you.
Your donation — as little as $5 — helps us create more content that matters to you and your community, and to reach more people where they are – whether that’s radio, podcasts or online.
When you contribute directly to Marketplace, you become a partner in that mission: someone who understands that when we all get smarter, everybody wins.